HLA-matched versus haploidentical donor transplantation with post-transplant cyclophosphamide: a study on behalf of the donor/source working group of the Japanese society for transplantation and cellular therapy

Abstract Post-transplant cyclophosphamide (PTCy) is now being increasingly applied to HLA-matched donor (MD) transplantation. Prior studies in Western countries have demonstrated that allogeneic hematopoietic cell transplantation (allo-HCT) employing PTCy yields better outcomes with HLA-matched dono...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yosuke Nakaya, Hirohisa Nakamae, Junichi Sugita, Junya Kanda, Yuta Hasegawa, Tetsuya Eto, Takahiro Fukuda, Naoki Kurita, Nobuhiro Hiramoto, Koji Nagafuji, Shuichi Ota, Noboru Asada, Toshihiko Ando, Toshiro Kawakita, Takashi Akasaka, Yasuo Mori, Tomohiko Kamimura, Makoto Onizuka, Yoshiko Atsuta, Hideki Nakasone
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Springer 2026-04-01
סדרה:	Annals of Hematology
נושאים:	Post-transplant cyclophosphamide Matched donor Haploidentical donor Graft-versus-host disease Hematological malignancies.
גישה מקוונת:	https://doi.org/10.1007/s00277-026-07014-z
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!